30 November 2022

Just Can’t Get Enough of Hydroxychloroquine

When it comes to hydroxychloroquine dosing, issues on efficacy, toxicity and therapeutic thresholds may affect the optimal use of this important drug. Following are three abstracts presented during the meeting that address these topics.

Fertility issues in SpA Dr. Sheila Reyes ( @RHEUMarampa) speaks with Dr. Sabrina Hamroun about abstract 1673 at #ACR22

Tweet Author

RheumNow

Tweet Content

Fertility issues in SpA Dr. Sheila Reyes ( @RHEUMarampa) speaks with Dr. Sabrina Hamroun about abstract 1673 at #ACR22. https://t.co/SvCuE4fx04 https://t.co/DAveKT29J8

Links

https://bit.ly/3H4r4tY

Does Race play a role in Mycophenolate Response in Scleroderma Dr. Eric Dein ( @ericdeinmd) speaks with Dr. Lauren Smi

Tweet Author

RheumNow

Tweet Content

Does Race play a role in Mycophenolate Response in Scleroderma Dr. Eric Dein ( @ericdeinmd) speaks with Dr. Lauren Smith about abstract 0521 at #ACR22. https://t.co/3lcVjfMsub https://t.co/P3XcsiXgWa

Links

https://bit.ly/3XLMSkm

Bouncebackability portends increased risk of adverse outcomes in RA

Copays Reduce Adherence to SLE Medications Dr. Michael Putman ( @EBRheum) reports on abstract 1115 at #ACR22 Convergen

Tweet Author

RheumNow

Tweet Content

Copays Reduce Adherence to SLE Medications Dr. Michael Putman ( @EBRheum) reports on abstract 1115 at #ACR22 Convergence in Philadelphia, PA. https://t.co/VLyMTSLFCf https://t.co/0nOA0b1576

Links

https://bit.ly/3EQzLFE

Can we accurately capture disease activity in pregnant patients with AS?

Proceedings of the Royal Society of Medicine and Fibromyalgia Action UK Webinar: Fibromyalgia in the 21st century: Redef

Tweet Author

RheumNow

Tweet Content

Proceedings of the Royal Society of Medicine and Fibromyalgia Action UK Webinar: Fibromyalgia in the 21st century: Redefining care. https://t.co/6k4Thx4ZSN https://t.co/1TfapVGMoe

Links

https://bit.ly/3gMBcgi

Study of 1207 joints in 55 RA pts shows that Xray progression over 2 yrs is significantly assoc w/ US Power Doppler (OR

Tweet Author

RheumNow

Tweet Content

Study of 1207 joints in 55 RA pts shows that Xray progression over 2 yrs is significantly assoc w/ US Power Doppler (OR 2.92), erosions (OR 4.74), but also with Joint tenderness w/o swelling (OR 1.85) ! (Less signif w/ PsA) https://t.co/gue5jt6Xdx https://t.co/vhFBWTgEHW

Links

https://bit.ly/3VI0hYP

Mayo LUMEN study looked at SLE nephritis incidence betw 1976 -2018, & showed that LN increased over past 4 decades.

Tweet Author

RheumNow

Tweet Content

Mayo LUMEN study looked at SLE nephritis incidence betw 1976 -2018, & showed that LN increased over past 4 decades. LN patients have poor outcomes w/ higer rates of ESRD & mortality rates (SMR 6.33); @10 yr survival =70% & 13% ESRD https://t.co/QDDTORSgyZ https://t.co/89ldzxhuMk

Links

https://bit.ly/3ONT6Ma

Thinking Outside the Box: Novel Strategies for Early Detection of AxSpA Early diagnosis of AxSpA remains a challenge.

Tweet Author

RheumNow

Tweet Content

Thinking Outside the Box: Novel Strategies for Early Detection of AxSpA Early diagnosis of AxSpA remains a challenge. Strategies to identify patients with suspected inflammatory back pain in the general population is critical. https://t.co/LsKOOHDOJI https://t.co/NARG61vBSn

Links

https://bit.ly/3gIogZ1

Topics

Just Can’t Get Enough of Hydroxychloroquine

Fertility issues in SpA Dr. Sheila Reyes ( @RHEUMarampa) speaks with Dr. Sabrina Hamroun about abstract 1673 at #ACR22

Does Race play a role in Mycophenolate Response in Scleroderma Dr. Eric Dein ( @ericdeinmd) speaks with Dr. Lauren Smi

Bouncebackability portends increased risk of adverse outcomes in RA

Copays Reduce Adherence to SLE Medications Dr. Michael Putman ( @EBRheum) reports on abstract 1115 at #ACR22 Convergen

Can we accurately capture disease activity in pregnant patients with AS?

Proceedings of the Royal Society of Medicine and Fibromyalgia Action UK Webinar: Fibromyalgia in the 21st century: Redef

Study of 1207 joints in 55 RA pts shows that Xray progression over 2 yrs is significantly assoc w/ US Power Doppler (OR

Mayo LUMEN study looked at SLE nephritis incidence betw 1976 -2018, & showed that LN increased over past 4 decades.

Thinking Outside the Box: Novel Strategies for Early Detection of AxSpA Early diagnosis of AxSpA remains a challenge.

Do you get our email newsletter?

Just Can’t Get Enough of Hydroxychloroquine

Fertility issues in SpA Dr. Sheila Reyes ( @RHEUMarampa) speaks with Dr. Sabrina Hamroun about abstract 1673 at #ACR22

Does Race play a role in Mycophenolate Response in Scleroderma Dr. Eric Dein ( @ericdeinmd) speaks with Dr. Lauren Smi

Bouncebackability portends increased risk of adverse outcomes in RA

Copays Reduce Adherence to SLE Medications Dr. Michael Putman ( @EBRheum) reports on abstract 1115 at #ACR22 Convergen

Can we accurately capture disease activity in pregnant patients with AS?

Proceedings of the Royal Society of Medicine and Fibromyalgia Action UK Webinar: Fibromyalgia in the 21st century: Redef

Study of 1207 joints in 55 RA pts shows that Xray progression over 2 yrs is significantly assoc w/ US Power Doppler (OR

Mayo LUMEN study looked at SLE nephritis incidence betw 1976 -2018, &amp; showed that LN increased over past 4 decades.

Thinking Outside the Box: Novel Strategies for Early Detection of AxSpA Early diagnosis of AxSpA remains a challenge.

Mayo LUMEN study looked at SLE nephritis incidence betw 1976 -2018, & showed that LN increased over past 4 decades.